Sigma Advanced System Ltd
Incorporated in 1999, Sigma Advanced Systems is a Hyderabad-based aerospace and defense manufacturing company[1]
- Market Cap ₹ 7,335 Cr.
- Current Price ₹ 416
- High / Low ₹ 446 / 79.5
- Stock P/E 36.6
- Book Value ₹ 26.9
- Dividend Yield 0.00 %
- ROCE 54.5 %
- ROE 58.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 170% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.9%
- Promoter holding has increased by 36.2% over last quarter.
Cons
- Stock is trading at 15.5 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Earnings include an other income of Rs.229 Cr.
- Company has high debtors of 330 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Aerospace & Defense Aerospace & Defense
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 15m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | 29 | 31 | 29 | 24 | 20 | 16 | 14 | 2 | 0 | 0 | 158 | |
| 45 | 26 | 35 | 31 | 28 | 19 | 16 | 33 | 20 | 9 | 10 | 139 | |
| Operating Profit | 6 | 3 | -4 | -3 | -5 | 1 | 1 | -18 | -18 | -9 | -10 | 19 |
| OPM % | 11% | 11% | -14% | -9% | -20% | 6% | 4% | -131% | -898% | 14% | 12% | |
| 1 | 1 | 8 | 1 | 10 | 6 | 7 | 30 | 43 | 37 | 41 | 229 | |
| Interest | 3 | 2 | 2 | 3 | 4 | 4 | 3 | 2 | 11 | 17 | 18 | 10 |
| Depreciation | 3 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Profit before tax | 0 | 1 | 1 | -6 | 1 | 1 | 1 | 6 | 11 | 8 | 8 | 234 |
| Tax % | -425% | 53% | -84% | -11% | 46% | -8% | -1% | 10% | 0% | 8% | 0% | 14% |
| 1 | 0 | 1 | -5 | 0 | 1 | 1 | 6 | 11 | 8 | 8 | 201 | |
| EPS in Rs | 0.08 | 0.06 | 0.15 | -0.67 | 0.06 | 0.08 | 0.19 | 0.76 | 1.56 | 1.02 | 1.15 | 11.38 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 57% |
| 3 Years: | 331% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 84% |
| 5 Years: | 170% |
| 3 Years: | 168% |
| TTM: | 2266% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 47% |
| 5 Years: | 109% |
| 3 Years: | 132% |
| 1 Year: | 405% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 21% |
| 3 Years: | 29% |
| Last Year: | 58% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 44 | 44 | 44 | 44 | 44 | 44 | 74 | 74 | 74 | 74 | 176 |
| Reserves | 130 | 101 | 102 | 97 | 103 | 104 | 105 | 111 | 122 | 130 | 138 | 298 |
| 17 | 17 | 16 | 17 | 12 | 9 | 6 | 29 | 146 | 147 | 139 | 71 | |
| 18 | 20 | 66 | 94 | 127 | 133 | 123 | 43 | 38 | 38 | 82 | 81 | |
| Total Liabilities | 210 | 182 | 228 | 253 | 287 | 291 | 278 | 256 | 380 | 389 | 433 | 626 |
| 47 | 61 | 55 | 13 | 105 | 135 | 138 | 185 | 179 | 187 | 200 | 28 | |
| CWIP | 0 | 0 | 0 | 58 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 69 | 56 | 56 | 56 | 34 | 34 | 34 | 7 | 136 | 136 | 136 | 10 |
| 94 | 65 | 117 | 126 | 117 | 122 | 107 | 65 | 64 | 66 | 97 | 589 | |
| Total Assets | 210 | 182 | 228 | 253 | 287 | 291 | 278 | 256 | 380 | 389 | 433 | 626 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 6 | 3 | 18 | 48 | 7 | 11 | 23 | 13 | 23 | 37 | -135 | |
| -1 | -3 | -2 | -16 | -39 | -1 | -1 | -42 | -147 | 10 | -19 | 227 | |
| -3 | -2 | -2 | -2 | -9 | -7 | -10 | 51 | 103 | -17 | -26 | -90 | |
| Net Cash Flow | -3 | 0 | -2 | -0 | 1 | -1 | 0 | 32 | -30 | 15 | -8 | 2 |
| Free Cash Flow | -0 | -8 | 0 | 2 | 10 | 7 | 10 | 23 | 17 | 11 | 20 | 219 |
| CFO/OP | 14% | 197% | -45% | -670% | -1,040% | 621% | 1,574% | -128% | -73% | -253% | -366% | -664% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 437 | 409 | 424 | 610 | 590 | 800 | 626 | 232 | 0 | 330 | ||
| Inventory Days | 57 | |||||||||||
| Days Payable | 185 | |||||||||||
| Cash Conversion Cycle | 437 | 409 | 424 | 610 | 590 | 800 | 626 | 232 | 0 | 202 | ||
| Working Capital Days | 416 | 347 | 511 | -532 | -1,179 | -1,269 | -1,487 | 138 | 4,964 | 291 | ||
| ROCE % | 2% | 2% | -3% | -1% | 3% | 3% | 3% | 3% | 8% | 7% | 8% | 54% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Nov 2023 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Geographic Revenue Share - APAC/India/EMEA % |
|
|||||||||
| Geographic Revenue Share - LATAM % |
||||||||||
| Geographic Revenue Share - USA & Canada % |
||||||||||
| Patents Awarded Number |
||||||||||
| Patents Filed Number |
||||||||||
| Leasable Property Area (IT Park) Million Sq. Ft. |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (LODR) Regulations, 2015, As Amended From Time To Time ('SEBI Listing Regulations')
1d - Board meeting on June 4, 2026 to consider preferential equity issue and EGM approval.
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
27 May - Postal ballot seeks reappointment of Mr. Sivalenka Kalyan Vijay as independent director from June 28, 2026.
-
Appointment of Company Secretary and Compliance Officer
25 May - May 25, 2026 board approved FY26 audited results, reappointed independent director, and changed company secretary.
-
Announcement under Regulation 30 (LODR)-Change in Management
25 May - On May 25, 2026, board approved FY26 audited results, reappointed independent director, and changed Company Secretary.
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
25 May - Board approved FY26 audited results, reappointed independent director, accepted CS resignation, appointed new CS, and paid Reg 17 fine.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Business Overview:[1]
MSL is focused on Pharma, Aerospace and Defense Electronics areas, is in the process of acquiring a few companies, and intend to provide centralized corporate, technology, finance, leadership /management support services to such subsidiaries /associate companies